ew laser treatment of MTM study
- Conditions
- myopic traction maculopathy
- Registration Number
- JPRN-jRCTs032190239
- Lead Sponsor
- Ohno-Matsui Kyoko
- Brief Summary
Five myopic traction maculopathy patients with decreased vision were enrolled and received Nd:YAG laser internal limiting membrane ablation at the peripheral macular area. There was no unpredictable adverse event. There was no significant change of retinal thickness both at the fovea and at the point of laser treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 5
1) Myopic traction maculopathy with ocular axial length of more than 26.5 mm
2) Decreased visual acuity caused by myopic traction maculopathy which diagnosed by two ophthalomologists who are specialized in myopia
3) Age of more than 20 years old
4) Written informed consent
5) Judged as an appropriate study participant by two ophthalomologists who are specialized in myopia
1) Pupil diameter of less than 3 mm with mydriatic examination
2) Opacity of cornea, lens, or vitreous which prevent image examination of ocular fundi.
3) Severe cardiopulmonary disease
4) Disability to keep sitting position
5) Judged as an inappropriate study participant by two ophthalomologists who are specialized in myopia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Retinal thickness at treated cite 6 months after treatment
- Secondary Outcome Measures
Name Time Method Central retinal thickness at treated cites and visual acuity at 6 months after treatment